Zhengye Biotechnology Holding Limited
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $93.2M
- Price
- $2.04
- % Change (Daily % change from the live per-ticker quote feed.)
- +7.94%
- Volume
- 238.9K
About
Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.
Quick stats
Shares outstanding45.7M
Computed float4.4M
Float / shares9.7%
Key info
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001975641
Websitehttps://www.jlzybio.com
AI Summary
AI-generated1/4
standardbullishregulatory
Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement
Zhengye Biotechnology received notification from Nasdaq that it has regained compliance with the minimum bid price requirement of $1.00 per share.
The company’s Class A ordinary shares closed at or above $1.00 for ten consecutive business days from July 20 to August 4, curing the deficiency identified in late May.
Zhengye will continue to be listed on the Nasdaq Capital Market under the symbol ZYBT.